Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials

OBJECTIVES: To assess the efficacy and safety profile of add‐on cannabidiol (CBD) in patients with Lennox–Gastaut syndrome (LGS) and Dravet syndrome (DS) on clobazam and in the overall population of four randomized, controlled phase 3 trials. METHODS: Patients received plant‐derived, highly purified...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunning, Boudewijn, Mazurkiewicz‐Bełdzińska, Maria, Chin, Richard F. M., Bhathal, Hari, Nortvedt, Charlotte, Dunayevich, Eduardo, Checketts, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821324/
https://www.ncbi.nlm.nih.gov/pubmed/32969022
http://dx.doi.org/10.1111/ane.13351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821324/
https://www.ncbi.nlm.nih.gov/pubmed/32969022
http://dx.doi.org/10.1111/ane.13351

Ejemplares similares